MYnd Analytics Awarded European Patent on Neuromodulation Platform; Predicts Patients Likely to Respond to TMS for Treating Depression - GlobeNewswire

Submitted by Anonymous (not verified) on Thu, 03/28/2019 - 13:20

MYnd Analytics Awarded European Patent on Neuromodulation Platform; Predicts Patients Likely to Respond to TMS for Treating Depression  GlobeNewswireMISSION VIEJO, Calif., March 28, 2019 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a behavioral health company with tools and ...